The utility of prescreening for hepatitis A in military recruits prior to vaccination

Military Medicine

Volumn 167, Issue 11, 2002, Pages 907-910

  Duncan, Marten B ^a   Hirota, William K ^a   Tsuchida, Amy ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS A ANTIBODY; HEPATITIS A VACCINE;

ADULT; ANTIBODY TITER; ARTICLE; CAUCASIAN; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DEMOGRAPHY; DRUG COST; FEMALE; HEALTH CARE COST; HEPATITIS A; HEPATITIS A VIRUS; HUMAN; IMMUNITY; IMMUNIZATION; INFECTION PREVENTION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; SCREENING; SERODIAGNOSIS; SOLDIER; UNITED STATES; VACCINATION;

EID: 0036846725     PISSN: 00264075     EISSN: None     Source Type: Journal    
DOI: 10.1093/milmed/167.11.907     Document Type: Article

References (22)

1. Hoke CH, Binn LN, Egan JE, et al: Hepatitis A in the U.S. Army: Epidemiology and vaccine development. Vaccine 1992; 10[Suppl 1): S75-9.
2. Steffen R, Kane M, Shapiro C, et al: Epidemiology and prevention of hepatitis A in travelers. J Am Med Assoc 1994; 272: 885-9.
3. Werzberger A, Kuter B, Nalin D: Six years' follow-up after hepatitis A vaccination. N Engl J Med 1998; 338: 1160.
4. Van Damme P, Cramm T, De Groote, Safary A, Meheus A: Inactivated hepatitis A vaccine: Reactogenicity, immunogenicity, and long-term antibody persistence. J Med Virol 1994; 44: 446-51.
5. Defrantes R, Feighner B, Binn L, et al: Immunization of U.S. soldiers with a two-dose primary series of inactivated hepatitis A vaccine: Early immune response, persistence of antibody, and response to a third dose at one year. J Infect Dis 1995; 171(Suppl 1): S61-9.
6. Sjogren M, Hoke C, Binn L, et al: Immunogenicity of an inactivated hepatitis A vaccine. Ann Intern Med 1991; 114: 470-1.
7. Hollinger B, Eickhoff T, Gershon A, Jong E, Koff R: Discussion: Who should receive hepatitis A vaccine: A strategy for controlling hepatitis A in the United States. J Infect Dis 1995; 171(Suppl 1): S73-7.
8. Saab S, Martin P, Yee H: A simple cost-decision analysis model comparing two strategies for hepatitis A vaccination. Am J Med 2000; 109: 241-3.
9. Niu M, Salive M, Krueger C, Ellenberg S: Two-year review of hepatitis A vaccine safety: Data from the Vaccine Adverse Event Reporting System (VAERS). Clin Infect Dis 1998; 26: 1475-6.
10. Bryan J, Nelson M: Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines. Arch Intern Med 1994; 154: 663-8.
11. Schwartz E, Raveh D: The prevalence of hepatitis A antibodies among Israeli travelers and the economic feasibility of screening before vaccination. Int J Epidemiol 1998; 27: 118-20.
12. Center for Disease Control and Prevention: Prevention of hepatitis A through active or passive immunization: Recommendations of the Advisory Committee on Immunization Practices. Morb Mortal Wkly Rep 1999; 48: 1-30.
13. Hyams K, Struewing J, Gray G: Seroprevalence of hepatitis A, B, and C in a United States military recruit population. Milit Med 1992; 157: 579-82.
14. Tettmar RE, Masterton RG, Strike PW: Hepatitis A immunity in British adults: An assessment of the need for pre-immunization screening. J Infect 1987; 15: 39-43.
15. Kitson M, Connor M: The requirement for hepatitis A vaccine in Gurkha Soldiers. J R Army Med Corps 1998; 145: 84-5.
16. O'Connor J, Imperiale T, Singer M: Cost-effectiveness analysis of hepatitis A vaccination strategies for adults. Hepatology 1999; 30: 1077-81.
17. Rajan E, Shattock A, Fielding J: Cost-effective analysis of hepatitis A prevention in Ireland. Am J Gastroenterol 2000; 95: 223-6.
18. Das A: An economic analysis of different strategies of immunization against hepatitis A virus in developed countries. Hepatology 1999; 29: 548-52.
19. Van Doorslaer E, Tormans G, Van Damme P: Cost-effectiveness analysis of vaccination against hepatitis A in travelers. J Med Virol 1994; 44: 463-9.
20. Smith S, Weber S, Wiblin T, Nettleman M: Cost-effectiveness of hepatitis A vaccination in healthcare workers. Infect Control Hosp Epidemiol 1997; 18: 688-91.
21. Buckley D, Fahey T, Bevan G: The prevalence and direct costs of pre-immunization testing for hepatitis A in general practice. Br J Gen Pract 1996; 46: 541-2.
22. Buma AH, Beutels P, Van Damme P, Tormans G, Van Doorslaer E, Leentvaar-Kuijpers A: An economic evaluation of hepatitis A vaccination in Dutch military personnel. Milit Med 1998; 163: 564-7.